| Literature DB >> 31613885 |
Nina Østerås1, Tuva Moseng1, Leti van Bodegom-Vos2, Krysia Dziedzic3, Ibrahim Mdala4, Bård Natvig4, Jan Harald Røtterud5, Unni-Berit Schjervheim6, Thea Vliet Vlieland7, Øyvor Andreassen8, Jorun Nystuen Hansen8, Kåre Birger Hagen1.
Abstract
BACKGROUND: To improve quality of care for patients with hip and knee osteoarthritis (OA), a structured model for integrated OA care was developed based on international recommendations. The objective of this study was to assess the effectiveness of this model in primary care. METHODS ANDEntities:
Mesh:
Year: 2019 PMID: 31613885 PMCID: PMC6793845 DOI: 10.1371/journal.pmed.1002949
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Fig 1Stepped-wedge design, timeline, and patient recruitment rate.
All 6 municipalities (clusters) started the trial simultaneously with a control phase (general practitioners and physiotherapists providing usual care). At predefined time points about every second month, one by one the municipalities crossed from the control to the intervention phase (use of the SAMBA model) in a randomised order. Light cells in the figure represent control periods, and dark cells represent intervention periods. The asterisks indicate the timing of the interactive workshops before switching to the intervention phase. Patients recruited to the study during the control phase in any cluster constituted the control group, whereas patients recruited during the intervention phase constituted the intervention group. All patients responded to the baseline questionnaire and follow-up questionnaires at 3, 6, 9, and 12 months post-baseline. aLarge municipalities (clusters) had >20,000 inhabitants.
Fig 2The SAMBA model for integrated osteoarthritis care.
GP, general practitioner; OA, osteoarthritis; PT, physiotherapist.
Fig 3CONSORT patient flow diagram.
ITT, intention to treat; OA, osteoarthritis.
Baseline characteristics of patients, physiotherapists, and general practitioners.
| Variable | Patients | Physiotherapists | General practitioners | |
|---|---|---|---|---|
| Intervention group | Control group | |||
| 211 (74) | 68 (62) | 24 (65) | 17 (42) | |
| 63 (10) | 65 (10) | 42 (8) | 50 (12) | |
| 29 (6) | 28 (5) | |||
| 101 (36) | 35 (32) | |||
| Full- or part-time employed | 108 (38) | 37 (34) | ||
| Age retired | 112 (39) | 50 (46) | ||
| On sick leave | 15 (5) | 5 (5) | ||
| Receiving disability pension | 31 (11) | 11 (10) | ||
| Other | 20 (7) | 6 (6) | ||
| Knee | 174 (61) | 54 (49) | ||
| Hip | 100 (35) | 46 (42) | ||
| Other | 9 (3) | 9 (8) | ||
| No joint prosthesis | 258 (91) | 99 (91) | ||
| 1 joint | 14 (5) | 6 (6) | ||
| 2 joints | 6 (2) | 3 (3) | ||
| 3 joints | 6 (2) | 1 (1) | ||
| 7 (10) | 7 (6) | |||
| 5.4 (2.0) | 5.1(1.9) | |||
| 71 (25) | 28 (26) | |||
| 68 (20) | 68 (20) | |||
| 8 (2, 14) | 8 (3, 23) | |||
| 12 (4) | 21 (4) | |||
| 2 (2) | ||||
| 1,130 (296) | ||||
BMI, body mass index; IQR, interquartile range; KOOS/HOOS ADL subscale, Knee injury and Osteoarthritis Outcome Score/Hip disability and Osteoarthritis Outcome Score Activities of Daily Living subscale (score range 0–100, 100 = best); NRS, numeric rating scale (0–10, 0 = no pain, 10 = worst pain); OA, osteoarthritis; SD, standard deviation.
Primary outcome and individual item pass rates at baseline and 3 and 6 months of follow-up and mean difference between groups (n = 393).
| Outcome measure | Control group | Intervention group | Control versus intervention group, mean difference (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|
| T0 | T3 | T6 | T0 | T3 | T6 | T3 | T6 | |
| 37 | 42 | 41 | 39 | 58 | 60 | 16.5 (10.3, 22.6) | 18.9 (12.7, 25.1) | |
| Information about OA from a HP | 25 | 30 | 37 | 25 | 68 | 70 | ||
| Information about different treatment alternatives | 46 | 35 | 42 | 34 | 69 | 74 | ||
| Information on self-management | 24 | 35 | 36 | 26 | 75 | 80 | ||
| Information about importance of physical activity | 69 | 76 | 74 | 62 | 95 | 98 | ||
| Referred to HP for physical activity/exercise | 65 | 60 | 58 | 68 | 85 | 83 | ||
| Advised to lose weight | 25 | 35 | 39 | 43 | 54 | 55 | ||
| Referred for support to lose weight | 3 | 7 | 3 | 11 | 21 | 12 | ||
| Assessed for functional ability | 17 | 15 | 22 | 19 | 29 | 29 | ||
| Assessed the need for walking aids | 16 | 28 | 18 | 12 | 19 | 22 | ||
| Assessed the need for other aids | 9 | 6 | 9 | 6 | 8 | 11 | ||
| Joint pain assessed by HP | 53 | 53 | 48 | 59 | 63 | 64 | ||
| Paracetamol recommended as first line | 54 | 63 | 67 | 62 | 65 | 66 | ||
| Offered stronger pain killers | 40 | 43 | 39 | 42 | 47 | 44 | ||
| Information about anti-inflammatory medication | 51 | 50 | 54 | 55 | 63 | 66 | ||
| Offered steroid injection | 29 | 26 | 24 | 23 | 26 | 27 | ||
| Referred to orthopaedic surgeon | 30 | 37 | 36 | 30 | 26 | 33 | ||
**p < 0.001. Estimates are adjusted for patient age, sex, and secular time (number of months between study initiation and the patient entering the study).
aThe mean total pass rate was calculated on the group level (from individual patients’ pass rates) as the mean percentage of QI items passed, ranging from 0 100, with 100 representing the best quality of care.
bIndividual OA-QI v2 item pass rates were calculated as the proportion of patients reporting that the QI was passed divided by the proportion of patients who were eligible for that QI item (in percentage), ranging from 0 to 100, with 100 representing that all eligible patients reported pass for that QI item.
HP, health professional; OA, osteoarthritis; OA-QI v2, OsteoArthritis Quality Indicator questionnaire version 2; QI, quality indicator; T0, baseline; T3, 3-month follow-up; T6, 6-month follow-up.
Fig 4Mean patient-reported quality of care in the control group (n = 109) and intervention group (n = 284) at baseline and 3 and 6 months of follow-up.
Mean patient-reported quality of care with 95% confidence interval. Patient-reported quality of care captured by OsteoArthritis Quality Indicator questionnaire version 2 (0–100, 100 = best score).
Secondary outcomes at baseline and 3 and 6 months of follow-up and odds ratio between groups (n = 393).
| Outcome | Control group percent | Intervention group percent | Control versus intervention group, OR (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|
| T0 | T3 | T6 | T0 | T3 | T6 | T3 | T6 | |
| 48 | 25 | 30 | 52 | 36 | 22 | 2.5 (1.08, 5.73) | 0.7 (0.28, 1.52) | |
| 27 | 14 | 8 | 26 | 10 | 5 | 0.6 (0.17, 2.34) | 0.6 (0.13, 2.38) | |
| 6 | 10 | 13 | 9 | 4 | 6 | 0.2 (0.06, 0.73) | 0.3 (0.08, 0.80) | |
| 48 | 44 | 45 | 51 | 78 | 67 | 28.4 (8.30, 97.08) | 9.3 (2.87, 30.37) | |
| 69 | 69 | 67 | 72 | 70 | 69 | 1.3 (0.69, 2.54) | 1.3 (0.70, 2.51) | |
*p < 0.05
**p < 0.001. Estimates are adjusted for patient age, sex, and secular time (number of months between study initiation and the patient entering the study).
aTo fulfil the physical activity recommendations, the patients had to report moderate-intensity activity for 150 minutes or vigorous-intensity activity for 60 minutes per week, or a combination of these.
bOverweight: BMI ≥ 25 kg/m2; obese: BMI ≥ 30 kg/m2.
BMI, body mass index; OR, odds ratio; T0, baseline; T3, 3-month follow-up; T6, 6-month follow-up.